Extramammary Paget's disease classification: Difference between revisions
Jump to navigation
Jump to search
Simrat Sarai (talk | contribs) |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 27: | Line 27: | ||
:Axillary Extramammary Paget's Disease | :Axillary Extramammary Paget's Disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Axillary extramammary Paget's disease may, arise within the epidermis or from neoplasms in the local apocrine glands, however exclusion of neoplastic disease in the breast tissue is mandatory before a diagnosis of primary extramammary Paget's disease is made in this site. | *Axillary extramammary Paget's disease may, arise within the [[epidermis]] or from neoplasms in the local apocrine glands, however exclusion of neoplastic disease in the breast tissue is mandatory before a diagnosis of primary extramammary Paget's disease is made in this site. | ||
*Analysis of c-erbB-2 expression may be of use in this differential diagnosis. | *Analysis of c-erbB-2 expression may be of use in this differential diagnosis. | ||
|- | |- | ||
| Line 57: | Line 57: | ||
*Intraepithelial cutaneous Paget's disease of the usual type | *Intraepithelial cutaneous Paget's disease of the usual type | ||
*Intraepithelial cutaneous Paget's disease with invasion | *Intraepithelial cutaneous Paget's disease with invasion | ||
*Intraepithelial cutaneous Paget's disease as a manifestation of underlying | *Intraepithelial cutaneous Paget's disease as a manifestation of underlying [[adenocarcinoma]] of skin appendage | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Positive markers: Cytokeratin (CK7); Gross cystic disease fluid protein (GCDFP); Carcinoembryonic antigen (CEA) | *Positive markers: Cytokeratin (CK7); Gross cystic disease fluid protein (GCDFP); [[Carcinoembryonic antigen]] (CEA) | ||
*Negative markers: Uroplakin (UPK); Cytokeratin (CK20) | *Negative markers: Uroplakin (UPK); Cytokeratin (CK20) | ||
|- | |- | ||
| Line 66: | Line 66: | ||
|style="padding: 5px 5px; background: #F5F5F5;" | | |style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Positive markers: Cytokeratin (CK20); Carcinoembryonic antigen (CEA) | *Positive markers: Cytokeratin (CK20); Carcinoembryonic antigen (CEA) | ||
*Negative markers: Cytokeratin (CK7); Gross cystic disease fluid protein (GCDFP): Uroplakin (UPK) | *Negative markers: Cytokeratin (CK7); [[Gross cystic disease fluid protein]] (GCDFP): [[Uroplakin]] (UPK) | ||
|- | |- | ||
|style="padding: 5px 5px; background: #F5F5F5;" | Urothelial origin | |style="padding: 5px 5px; background: #F5F5F5;" | Urothelial origin | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Positive markers: Cytokeratin (CK7); Cytokeratin (CK20); Uroplakin (UPK) | *Positive markers: Cytokeratin (CK7); Cytokeratin (CK20); Uroplakin (UPK) | ||
*Negative markers: Gross cystic disease fluid protein (GCDFP15); Carcinoembryonic antigen (CEA) | *Negative markers: Gross cystic disease fluid protein (GCDFP15); [[Carcinoembryonic antigen]] (CEA) | ||
|- | |- | ||
|style="padding: 5px 5px; background: #F5F5F5;" | Other origin | |style="padding: 5px 5px; background: #F5F5F5;" | Other origin | ||
Revision as of 18:22, 5 February 2016
|
Extramammary Paget's disease Microchapters |
|
Differentiating Extramammary Paget's disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extramammary Paget's disease classification On the Web |
|
American Roentgen Ray Society Images of Extramammary Paget's disease classification |
|
Directions to Hospitals Treating Extramammary Paget's disease |
|
Risk calculators and risk factors for Extramammary Paget's disease classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Extramammary Paget's disease may be classified into two groups based on the origin of the Paget's cells. Extramammary Paget's disease may be classified into four subtypes based on site of origin and area affected.[1]
Classification
The classification of extramammary Paget's disease based on the site and area affeced is shown below in a tabular form:
| Type of Extramammary Paget's Disease | Description |
|---|---|
|
|
|
|
|
|
|
Extramammary Paget's disease may be classified based on the origin of the Paget's cells according to a classification system proposed by Wilkinson and Brown into two groups: primary (cutaneous) and secondary (non-cutaneous). Classification of extramammary Paget's disease into two groups is shown below in a tabular form:[1]
| Type of extramammary Paget's disease | Features | Useful marker |
|---|---|---|
| Primary (cutaneous origin) |
|
|
| Secondary (non-cutaneous origin) | Anorectal origin |
|
| Urothelial origin |
| |
| Other origin | Other origin antigen expression depends on primary tumor |
References
- ↑ 1.0 1.1 Wilkinson EJ, Brown HM (2002). "Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease". Hum Pathol. 33 (5): 549–54. PMID 12094382.
- ↑ Curtin JP, Rubin SC, Jones WB, Hoskins WJ, Lewis JL (1990). "Paget's disease of the vulva". Gynecol Oncol. 39 (3): 374–7. PMID 2175288.
- ↑ Goldblum JR, Hart WR (1997). "Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases". Am J Surg Pathol. 21 (10): 1178–87. PMID 9331290.
- ↑ Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C (1999). "Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision". Am J Obstet Gynecol. 180 (1 Pt 1): 24–7. PMID 9914572.
- ↑ van der Putte SC (1991). "Anogenital "sweat" glands. Histology and pathology of a gland that may mimic mammary glands". Am J Dermatopathol. 13 (6): 557–67. PMID 1666822.
- ↑ van der Putte SC, van Gorp LH (1994). "Adenocarcinoma of the mammary-like glands of the vulva: a concept unifying sweat gland carcinoma of the vulva, carcinoma of supernumerary mammary glands and extramammary Paget's disease". J Cutan Pathol. 21 (2): 157–63. PMID 8040464.
- ↑ 7.0 7.1 Powell FC, Bjornsson J, Doyle JA, Cooper AJ (1985). "Genital Paget's disease and urinary tract malignancy". J Am Acad Dermatol. 13 (1): 84–90. PMID 2993379.
- ↑ 8.0 8.1 Koga F, Gotoh S, Suzuki S (1997). "[A case of invasive bladder cancer with Pagetoid skin lesion of the vulva and anogenital Paget's disease]". Nihon Hinyokika Gakkai Zasshi. 88 (4): 503–6. PMID 9155118.
- ↑ Hayashibara Y, Ikeda S (1988). "[Extramammary Paget's disease with internal malignancies]". Gan To Kagaku Ryoho. 15 (4 Pt 2-3): 1569–75. PMID 2837997.
- ↑ Nakano S, Narita R, Tabaru A, Ogami Y, Otsuki M (1995). "Bile duct cancer associated with extramammary Paget's disease". Am J Gastroenterol. 90 (3): 507–8. PMID 7872301.
- ↑ Popiolek DA, Hajdu SI, Gal D (1998). "Synchronous Paget's disease of the vulva and breast". Gynecol Oncol. 71 (1): 137–40. doi:10.1006/gyno.1998.5136. PMID 9784335.
- ↑ Goldblum JR, Hart WR (1998). "Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma". Am J Surg Pathol. 22 (2): 170–9. PMID 9500217.
- ↑ Allan SJ, McLaren K, Aldridge RD (1998). "Paget's disease of the scrotum: a case exhibiting positive prostate-specific antigen staining and associated prostatic adenocarcinoma". Br J Dermatol. 138 (4): 689–91. PMID 9640381.